Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals shares plunged 37.33 percent on over 22.5 million shares traded Wednesday to close at $7.79 a share. The company “anticipates a change in ordering patterns of FUSILEV” and sales for the first quarter are expected to be approximately $10 to $15 million.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on